(Q28294538)

ORCID Public Data File 2021

author name string

Anne-Marie Maurer

series ordinal

1

0 references

language of work or name

English

0 references

publication date

December 2006

0 references

published in

Growth Factors Journal

0 references

volume

24

0 references

issue

4

0 references

page(s)

242-52

0 references

cites work

In vivo effect of platelet factor 4 (PF4) and tetrapeptide AcSDKP on haemopoiesis of mice treated with 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Analysis of the role of chemokines in angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Platelet factor 4: an inhibitor of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

The multiple complexes formed by the interaction of platelet factor 4 with heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Platelet-derived CXC chemokines: old players in new games

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Interaction of platelet factor 4 with fibroblast growth factor 2 is stabilised by heparan sulphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

The role of megakaryocyte growth and development factor in terminal stages of thrombopoiesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

A tricistronic retroviral vector expressing natural antiangiogenic factors inhibits angiogenesis in vitro, but is not able to block tumor progression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Amino acid sequence of human platelet factor 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Human recombinant granulocyte-macrophage colony stimulating factor and interleukin 3 have overlapping but distinct hematopoietic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

The biology of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Fundamental Concepts of the Angiogenic Process

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Human platelet factor 4 gene is mapped to 4q12----q21

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Carboxy-terminal peptides (C1-24 and C13-24 but not C1-13) of platelet factor 4 inhibit murine megakaryocytopoiesis, an activity which is neutralized by heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Suppression of tumor growth by viral vector-mediated gene transfer of N-terminal truncated platelet factor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Signal transduction of chemokine platelet factor 4 in human erythroleukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Live attenuated Salmonella carrying platelet factor 4 cDNAs as radioprotectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Human platelet factor 4 monomer-dimer-tetramer equilibria investigated by 1H NMR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Basic fibroblast growth factor expression is required for clonogenic growth of human glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Endothelial receptor tyrosine kinases involved in angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Platelet antiheparin proteins and antithrombin III interact with different binding sites on heparin molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

New synthesis of a platelet-specific protein: platelet factor 4 synthesis in a megakaryocyte-enriched rabbit bone marrow culture system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Interactions of platelet factor 4 with the vessel wall

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Platelet factor 4 blocks the binding of basic fibroblast growth factor to the receptor and inhibits the spontaneous migration of vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Carboxyl-terminal heparin-binding fragments of platelet factor 4 retain the blocking effect on the receptor binding of basic fibroblast growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Fraxiparin, a low-molecular-weight heparin, stimulates megakaryocytopoiesis in vitro and in vivo in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Cancer CXC chemokine networks and tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

A model of the platelet factor 4 complex with heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Preferential self-association of basic fibroblast growth factor is stabilized by heparin during receptor dimerization and activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Primary structure of human platelet factor 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

cMpl ligand is a humoral regulator of megakaryocytopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Chemokines, chemokine receptors and hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Crystal structure of recombinant human platelet factor 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Platelet factor 4 enhances the adhesion of normal and leukemic hematopoietic stem/progenitor cells to endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Chemokines: a new classification system and their role in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225

Protamine is an inhibitor of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190600988225